ArticleCancer discovery2016

Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.

David S Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.